biotechnology

venture capital

AN Venture Partners Announces Final Close of $200M Fund I, MUFG & SMBC Participate

AN Venture Partners (ANV), a global biotech venture capital firm, announced the final close of its first fund, AN Venture Partners I, achieving its target of USD 200m (JPY 29bn), one of the largest Japan-focused biotech venture capital funds to date, and also one of the largest first-time biotech venture

venture capital

SMBC Invests in AN Venture Partners

Sumitomo Mitsui Banking Corporation has entered into an investment agreement with AN Venture Partners I, operated by ANV Management, which invests in the biotechnology sector. ANV was established in 2022 with the purpose of creating global biotechnology companies based primarily on excellent research and drug discovery seeds from Japanese universities,